Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
CPI-613 in Treating Patients With Myelodysplastic Syndromes Who Failed Previous Therapy
ClinicalTrials.gov study NCT01902381. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00425477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01729845. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00475150. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01804101. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01842646. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PR1 Vaccination in Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00893997. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory
ClinicalTrials.gov study NCT05146739. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
ClinicalTrials.gov study NCT06499285. IPD Sharing: YES. Countries: 25. Publications: 0.
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01471444. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (M
ClinicalTrials.gov study NCT04079296. IPD Sharing: NO. Countries: 2. Publications: 0.
CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02019069. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes
ClinicalTrials.gov study NCT05168202. IPD Sharing: Not stated. Countries: 9. Publications: 0.
WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02666950. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01378416. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01041846. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01599325. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes
ClinicalTrials.gov study NCT02240706. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Myelodysplastic Syndrome--CDA-2 Hematological Improvement National Affirmation Study
ClinicalTrials.gov study NCT03335943. IPD Sharing: NO. Countries: 0. Publications: 2.
Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study
ClinicalTrials.gov study NCT01326845. IPD Sharing: Not stated. Countries: 4. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.